AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 NOV 3 - (NewsRx.com & NewsRx.net) -- Aventis (AVE), part of the sanofi-aventis Group, announced that the company has shipped more than 30 million doses of its influenza vaccine, Fluzone, Influenza Virus Vaccine, for the upcoming season.
Aventis Pasteur, the human vaccines business of Aventis, is on schedule to achieving the company's goal of providing Fluzone vaccine to all its customers in time for the orderly immunization of consumers. These doses represent the largest shipment of influenza vaccine by any manufacturer for this influenza season.
"Aventis Pasteur is once again pleased to provide on-schedule delivery of influenza vaccine, allowing health-care providers to begin immunizing patients - especially those at greatest risk for influenza-related complications - early during the immunization season," said Jim Robinson, vice president of industrial operations for Aventis Pasteur in the U.S.
Aventis Pasteur began to ship Fluzone vaccine in August, 1 month earlier than the company originally informed customers. Earlier shipments became possible due to a strong production year. The company estimates it will produce more than 52 million doses of Fluzone vaccine for the 2004-05 influenza season.
The 2004-05 influenza vaccine formulation contains the A/Fujian/411/2002 (H3N2)-like, A/New Caledonia/20/99 (H1N1)-like and B/Shanghai/361/2002-like strains. The three strains for the new influenza vaccine formulation were confirmed by the U.S. Food & Drug Administration ...
Source: HighBeam Research, Thirty million doses of influenza vaccine shipped to healthcare...